| References |
| 1 |
Hunninghake DB, Hibbard DM "Influence of time intervals for cholestyramine dosing on the absorption of hydrochlorothiazide." Clin Pharmacol Ther 39 (1986): 329-34. [PMID: 3948472]
|
| 2 |
Hunninghake DB, King S, LaCroix K "The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide." Int J Clin Pharmacol Ther Toxicol 20 (1982): 151-4. [PMID: 7076343]
|
| 3 |
Product Information. Atacand HCT (candesartan-hydrochlorothiazide) AstraZeneca Pharmaceuticals, Wilmington, DE.
|
| 4 |
Product Information. Questran (cholestyramine). Par Pharmaceutical Inc, Chestnut Ridge, NY.
|